Henry Schein, Inc.

NMS: HSIC
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Henry Schein, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get HSIC Z-Score →

About Henry Schein, Inc.

Healthcare Medical Distribution
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

📊 Fundamental Analysis

Henry Schein, Inc. demonstrates a profit margin of 3.0%, which is below the sector average, suggesting competitive pressure.

The company recently reported 7.7% revenue growth, which is modest compared to its industry peers.

Return on Equity (ROE) is 8.7%, which suggests room for improvement in capital utilization.

At a current price of $75.34, HSIC currently sits at the 49th percentile of its 52-week range (Range: $61.95 - $89.29).

💰 Valuation Insight

HSIC is valued broadly in line with the sector at a PE of 23.04. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$8.65B
Trailing P/E
23.04
Forward P/E
12.82
Beta (5Y)
0.88
52W High
$89.29
52W Low
$61.95
Avg Volume
1.35M
Day High
Day Low
Get HSIC Z-Score on Dashboard 🚀